Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Massachusetts General Hospital
University of Chicago
University of Pittsburgh
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sir Mortimer B. Davis - Jewish General Hospital
Brain Inflammation Collaborative
Abramson Cancer Center at Penn Medicine
University of Pittsburgh
University of Pittsburgh
Brigham and Women's Hospital
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Essen Biotech
Assistance Publique - Hôpitaux de Paris
University of California, Davis
First Affiliated Hospital of Wenzhou Medical University
University of California, San Diego
University of California, San Diego
University of California, San Diego
MiraKind
Yale University
Imperial College London
First Affiliated Hospital of Wenzhou Medical University
Tongji Hospital
Tongji Hospital
University College, London
Washington University School of Medicine
RenJi Hospital
Assistance Publique - Hôpitaux de Paris
University of Haifa
Georgetown University
The Second Affiliated Hospital of Chongqing Medical University
Sohag University
The Netherlands Cancer Institute
Alliance Foundation Trials, LLC.
Poitiers University Hospital
Hellenic Cooperative Oncology Group
University of Southern Denmark
Groupe Hospitalier Pitie-Salpetriere
University Hospital, Brest
Tianjin Medical University Cancer Institute and Hospital
Peking Union Medical College Hospital
National Pediatric Neuroinflammation Organization, Inc.
Emory University
Jonsson Comprehensive Cancer Center
Chulalongkorn University
National University of Natural Medicine